Acoustic startle reduction in cocaine dependence

声学惊吓可减少可卡因依赖

基本信息

  • 批准号:
    7094500
  • 负责人:
  • 金额:
    $ 31.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-06-01 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chronic cocaine administration leads to changes in brain function that persist long after the acute withdrawal phase. The acoustic startle response (ASR) is a well characterized reflexive response to a sudden acoustic stimulus. The ASR is mediated by a simple 3-synapse subcortical circuit; it is modulated in part by brain areas and neurotransmitters associated with cocaine administration. Our initial study and subsequent replication reveals a profound diminution of the ASR in cocaine-dependent subjects after a brief period of abstinence. Little is known about the exact time course during which this robust abnormality develops. Work using rodent models by our group and others also indicates a reduction in the ASR after recurrent cocaine administration that is consistent with our clinical finding. However, we cannot be certain that startle reductions in these subjects did not, at least in part, predate their cocaine addiction as a vulnerability factor. Our preliminary findings indicate that first degree relatives of cocaine-dependent subjects also have reduced startle compared to healthy controls. The findings of low ASR in rats and humans during cocaine washout and low ASR in family members suggests there may be both a trait and state component of the startle reductions we have reported. We propose a translational project with both clinical and preclinical components that will advance our understanding of the clinical significance and underlying pathophysiology of cocaine-related startle reduction. The central objectives of this proposal are to dissect this finding with regard to its development and persistence in early and later phases of cocaine abstinence in humans (Specific Aims 1 and 2) and in rats (Specific Aims 5); to ascertain whether startle reduction and its potential normalization during later abstinence is a predictor of clinical course in human subjects with cocaine dependence (Specific Aim 3); and to examine whether startle reduction is, at least in part, a vulnerability trait for the development of cocaine dependence (Specific Aim 4). This latter Aim will be carried out in humans by testing siblings of cocaine-dependent subjects, and in rats by evaluating vulnerability to cocaine self-administration in high- vs. low-startling rats. Relevance to Public Health: Cocaine dependence is an enormous public health problem. The significance of this work lies in the potential for the ASR reduction to serve as a reliable, easily repeatable biological measure of cocaine-induced brain changes that may enhance outcome prediction so that tailored treatments may be directed at those patients most vulnerable to relapse, given the restriction of resources available for substance abuse treatment.
描述(由申请人提供):长期可卡因给药导致脑功能变化,在急性戒断期后持续很长时间。声惊吓反应(acoustic startle response,ASR)是一种对突发声刺激的反射性反应。ASR由简单的3-突触皮层下回路介导;它部分地由与可卡因给药相关的脑区和神经递质调节。我们的初步研究和随后的复制显示,可卡因依赖受试者在短暂戒断后的ASR大幅下降。很少有人知道确切的时间过程中,这种强大的异常发展。我们小组和其他人使用啮齿动物模型的工作也表明,在反复服用可卡因后,ASR降低,这与我们的临床发现一致。然而,我们不能确定这些受试者的惊人减少至少在一定程度上没有早于他们的可卡因成瘾作为脆弱性因素。我们的初步研究结果表明,可卡因依赖受试者的一级亲属与健康对照组相比也减少了惊吓。在可卡因洗脱期间,大鼠和人类的低ASR以及家庭成员的低ASR的发现表明,我们报告的惊吓减少可能既有特征也有状态成分。我们提出了一个翻译项目,临床和临床前的组成部分,将促进我们的临床意义和可卡因相关的惊吓减少的基础病理生理学的理解。本提案的中心目标是剖析这一发现,即在人类可卡因戒断的早期和后期阶段,(具体目标1和2)和大鼠(具体目的5);确定在后来戒断期间惊吓减少及其潜在正常化是否是可卡因依赖人类受试者临床病程的预测因子(具体目标3);并检查惊吓减少是否至少部分是可卡因依赖发展的易感性特征(具体目标4)。后一个目标将通过测试可卡因依赖受试者的兄弟姐妹在人类中进行,并通过评估高与低惊吓大鼠对可卡因自我给药的脆弱性在大鼠中进行。与公共卫生的相关性:可卡因依赖是一个巨大的公共卫生问题。这项工作的意义在于,ASR降低可能作为可卡因诱导的大脑变化的可靠,易于重复的生物学测量,这可能会增强结果预测,以便针对那些最容易复发的患者进行量身定制的治疗,因为药物滥用治疗的资源有限。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Erica J Duncan其他文献

Erica J Duncan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Erica J Duncan', 18)}}的其他基金

Molecular pathways of the kynurenine system in the neuroimmunology and psychophysiology of schizophrenia.
犬尿氨酸系统在精神分裂症的神经免疫学和心理生理学中的分子途径。
  • 批准号:
    9766390
  • 财政年份:
    2018
  • 资助金额:
    $ 31.54万
  • 项目类别:
Aerobic Exercise for Cognition in Schizophrenia
有氧运动对精神分裂症认知能力的影响
  • 批准号:
    9029793
  • 财政年份:
    2016
  • 资助金额:
    $ 31.54万
  • 项目类别:
Aerobic Exercise for Cognition in Schizophrenia
有氧运动对精神分裂症认知能力的影响
  • 批准号:
    9212013
  • 财政年份:
    2016
  • 资助金额:
    $ 31.54万
  • 项目类别:
The role of kynurenine pathway activation in Toxoplasma-linked schizophrenia
犬尿氨酸途径激活在弓形虫相关精神分裂症中的作用
  • 批准号:
    8865387
  • 财政年份:
    2014
  • 资助金额:
    $ 31.54万
  • 项目类别:
The role of kynurenine pathway activation in Toxoplasma-linked schizophrenia
犬尿氨酸途径激活在弓形虫相关精神分裂症中的作用
  • 批准号:
    8732168
  • 财政年份:
    2014
  • 资助金额:
    $ 31.54万
  • 项目类别:
The role of kynurenine pathway activation in Toxoplasma-linked schizophrenia
犬尿氨酸途径激活在弓形虫相关精神分裂症中的作用
  • 批准号:
    8967202
  • 财政年份:
    2014
  • 资助金额:
    $ 31.54万
  • 项目类别:
Acoustic startle reduction in cocaine dependence
声学惊吓可减少可卡因依赖
  • 批准号:
    7586104
  • 财政年份:
    2006
  • 资助金额:
    $ 31.54万
  • 项目类别:
Acoustic startle reduction in cocaine dependence
声学惊吓可减少可卡因依赖
  • 批准号:
    7379982
  • 财政年份:
    2006
  • 资助金额:
    $ 31.54万
  • 项目类别:
Acoustic startle reduction in cocaine dependence
声学惊吓可减少可卡因依赖
  • 批准号:
    7236696
  • 财政年份:
    2006
  • 资助金额:
    $ 31.54万
  • 项目类别:
Acoustic startle reduction in cocaine dependence
声学惊吓可减少可卡因依赖
  • 批准号:
    7275232
  • 财政年份:
    2006
  • 资助金额:
    $ 31.54万
  • 项目类别:

相似国自然基金

抗可卡因(Cocaine)抗体酶的研制及实验研究
  • 批准号:
    39570633
  • 批准年份:
    1995
  • 资助金额:
    8.5 万元
  • 项目类别:
    面上项目

相似海外基金

Novel application of pharmaceutical AMD3100 to reduce risk in opioid use disorder: investigations of a causal relationship between CXCR4 expression and addiction vulnerability
药物 AMD3100 降低阿片类药物使用障碍风险的新应用:CXCR4 表达与成瘾脆弱性之间因果关系的研究
  • 批准号:
    10678062
  • 财政年份:
    2023
  • 资助金额:
    $ 31.54万
  • 项目类别:
Repurposing Metformin as a Treatment for Cocaine Use Disorder
重新利用二甲双胍治疗可卡因使用障碍
  • 批准号:
    10823844
  • 财政年份:
    2023
  • 资助金额:
    $ 31.54万
  • 项目类别:
Couples Motivational Interviewing to reduce drug use and HIV risk in vulnerable male couples
夫妻动机访谈,以减少弱势男性夫妇的吸毒和艾滋病毒风险
  • 批准号:
    10757544
  • 财政年份:
    2023
  • 资助金额:
    $ 31.54万
  • 项目类别:
Substance Use and Firearm Injuries among Medicaid-enrolled Youth
参加医疗补助的青少年的药物使用和枪伤
  • 批准号:
    10811094
  • 财政年份:
    2023
  • 资助金额:
    $ 31.54万
  • 项目类别:
Strategies to improve Utilization of Post-overdose Evidence-based Risk mitigation among Non-fatal Overdoses in VA (SUPER NOVA)
提高药物过量后利用率的策略 基于证据的 VA 非致命药物过量风险缓解策略 (SUPER NOVA)
  • 批准号:
    10425936
  • 财政年份:
    2023
  • 资助金额:
    $ 31.54万
  • 项目类别:
New psychoactive substance exposure among NYC nightclub and festival attendees
纽约夜总会和节日参加者接触新的精神活性物质
  • 批准号:
    10734617
  • 财政年份:
    2023
  • 资助金额:
    $ 31.54万
  • 项目类别:
Modular Virtual Reality Therapeutic for Opioid and Stimulant Use Disorders
针对阿片类药物和兴奋剂使用障碍的模块化虚拟现实治疗
  • 批准号:
    10784642
  • 财政年份:
    2023
  • 资助金额:
    $ 31.54万
  • 项目类别:
Innovations in Modeling Existing and Emerging Policies to Improve Warning Systems for Opioid Overdoses
现有和新兴政策建模创新,以改进阿片类药物过量预警系统
  • 批准号:
    10752283
  • 财政年份:
    2023
  • 资助金额:
    $ 31.54万
  • 项目类别:
RP7 Impact
RP7 影响
  • 批准号:
    10595907
  • 财政年份:
    2023
  • 资助金额:
    $ 31.54万
  • 项目类别:
Development and validation of a novel point-of-care technology for rapid non-targeted identification of emerging opioid and other drug threats
开发和验证一种新型即时护理技术,用于快速非靶向识别新出现的阿片类药物和其他药物威胁
  • 批准号:
    10775250
  • 财政年份:
    2023
  • 资助金额:
    $ 31.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了